Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Genetically Predicted Plasma Lipid Metabolites and Immune-Cell Phenotypes in Chronic Obstructive Pulmonary Disease: A Two-Sample Mendelian Randomization Study with Exploratory Reverse and Mediation Analyses.

Created on 09 Nov 2026

Authors

Minglong Xu, Bo Yao, Xue Xiao, Zhangli Peng

Published in

International journal of chronic obstructive pulmonary disease. Volume 21. Pages 630816. Epub Nov 04, 2026.

Abstract

To evaluate associations of genetically predicted plasma lipid metabolites and immune-cell phenotypes with chronic obstructive pulmonary disease (COPD) and assess candidate immune-mediated lipid-COPD pathways.
We conducted two-sample Mendelian randomization (MR) analyses using genome-wide association study summary statistics for COPD in 458,440 individuals of European ancestry (26,274 cases and 432,166 controls), 179 plasma lipid metabolites in 7,174 Finnish participants, and 731 immune-cell phenotypes in 3,757 Sardinian participants. Genetic instruments selected at P<1×10-5 were linkage-disequilibrium clumped, harmonized and screened for instrument strength. Inverse-variance weighting (IVW) was the primary estimator, with robust adjusted profile score (MR-RAPS) used for sensitivity analysis. Benjamini-Hochberg (BH) correction was applied separately across the complete lipid and immune-cell test families. Reverse MR of 13 selected lipids, cross-ancestry analyses using an East-Asian COPD outcome, and two-step MR of 18 previously selected candidate pathways were exploratory. Indirect effects were estimated, and complementary multivariable MR with conditional F-statistics were evaluated separately; BH correction covered the reverse and indirect-effect families.
Twenty-one lipid metabolites and 48 immune-cell phenotypes showed nominal IVW associations with COPD (P<0.05), however, none met the complete-family threshold of q<0.05. Six immune-cell phenotypes reached an exploratory (q<0.10) threshold. MR-RAPS estimates were generally directionally consistent with the European IVW estimates but did not identify any complete-family (q<0.05) associations. The cross-ancestry outcome analysis did not consistently support the focused European signals. None of the 18 indirect effects survived BH correction. For the pathway from phosphatidylcholine (16:0_20:4) to COPD through CD62L- myeloid dendritic cell absolute count, the indirect effect was 0.0037 (95% CI -0.0008 to 0.0083; P=0.110; BH q=0.138). Two reverse-MR associations were nominally significant, but neither survived correction across 13 tests (both BH q=0.140). Although multivariable MR identified several direct-effect patterns within the selected candidate set, these findings did not establish mediation.
The primary European analyses provided limited evidence for multiplicity-adjusted associations of the evaluated plasma lipid metabolites or immune-cell phenotypes with COPD, and none of the candidate indirect effects was statistically supported. Reverse-MR signals should therefore be considered hypothesis-generating and require validation in independent cohorts and experimental studies. The present findings do not support clinical risk prediction or diagnostic application.

PMID:
43001138
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement